A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cefprozil | CAS 92665-29-7 - Request Quote

Picture of Cefprozil
SZ CAT No:SZ-C116024
CAS No
92665-29-7
Mol.F.
C18H19N3O5S
Mol.Wt.
389.4
Inv. Status
Synthesis on demand
Rel. CAS No121123-17-9 (monohydrate)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Cefprozil is chemically (6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1EZ)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per EP). Cefprozil is supplied with detailed characterization data compliant with regulatory guideline. Cefprozil can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefprozil Monohydrate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 92665-29-7

Purchase 92665-29-7

Order 92665-29-7

Enquire 92665-29-7

price of 92665-29-7

92665-29-7 Supplier

92665-29-7 Manufacturer

92665-29-7 Exporter

buy high quality Cefprozil

Purchase Cefprozil

Cefprozil suppliers

Cefprozil manufacturers

Cefprozil price

Order Cefprozil

Enquire Cefprozil

Cefprozil cost

Cefprozil Supplier

Cefprozil Distributor

Cefprozil for Method Validation

Cefprozil Monohydrate Reference Standard

Cefprozil for ANDA Filing

Cefprozil for Forced Degradation Studies

Cefprozil Identification Standards

Cefprozil for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,